ClinicalTrials.Veeva

Menu

Immediate Post-placental Insertion of IUCD During Cesarean Delivery Versus 6 Week Post-Cesarean Insertion

A

ALshaimaa Aboalhassan Ali

Status and phase

Completed
Phase 1

Conditions

Mechanical Complication of Intrauterine Device

Treatments

Drug: IUCD

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of current study is to compare the rates of IUCD expulsion and complications in immediate post-placental insertion versus delayed IUCD insertion (6-weeks after cesarean delivery)

Full description

Intrauterine devices (IUDs) are among the most effective forms of contraception, offering greater than 99% efficacy per year of use and are completely reversible .

Post-placental intrauterine device (IUD) insertion is a safe, convenient, and effective option for postpartum contraception. "Post-placental" refers to insertion within 10-15 minutes of placental delivery, after vaginal or cesarean delivery.

Enrollment

200 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age: 18 -45
  • Singleton pregnancy at ≥32 weeks gestation at time of enrollment
  • Voluntarily requesting to IUD placement for postpartum contraception
  • Able to give consent and agree to the terms of the study

Exclusion criteria

  1. Uterine anomaly that preventing replacement of IUD.
  2. Chorioamnionitis (such as prolonged rupture of membranes >18 hours, prolonged labor >24 hours, fever >38C).
  3. Puerperal sepsis and unresolved postpartum hemorrhage.
  4. IUD allergy (copper).
  5. Systemic lupus erythematosus with severe thrombocytopenia

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

200 participants in 2 patient groups

Postplacental IUCD Insertion during Cesarean section
Active Comparator group
Description:
IUCD inserted postplacental removal
Treatment:
Drug: IUCD
6 Week Post-Cesarean Insertion of IUCD
Active Comparator group
Description:
IUCD inserted after six weeks post Cesarean section delivery
Treatment:
Drug: IUCD

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems